Macro-Molecular Drugs Shine as Profit Drivers for Pharma Companies
Macro-Molecular Drugs Shine as Profit Drivers for Pharma Companies
Attachment: A
BEIJING--May 19, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--In FIERCE Pharma's recently announced global top 20 list of best-selling drugs, 12 of them are macro-molecular drugs such as antibodies, vaccines and proteins.
Companies featured: AbbVie (NYSE:ABBV), Merck & Co. (NYSE:MRK), Regeneron Pharmaceuticals, Incorporated (NASDAQ:REGN), Johnson & Johnson (NYSE:JNJ), Bristol Myers Squibb (NYSE:BMY), Amgen Incorporated (NASDAQ:AMGN), Pfizer Incorporated (NYSE:PFE), Eli Lilly and Company (NYSE:LLY)
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- U.S. Supplement Production Brings Millions in Spending
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips